Docket Number:28A-990908
Inventor:John Yu, Alice Yu, H.C. Wu, Sheng-Hung Wang, Chen I-Ju
IP Status:US 8846623 B2、CN 、EU Pending
Abstract:
The technique was used homology modeling and computer docking to characterize several structural features of human protein GRP78, which is expressed on the cell surface in cancer cells but only in the cytoplasm of normal cells. The technique had thus developed and optimized several new tumor-targeted peptides [P-12, P-13, and P-6] via Biocore identification, in vitro binding, in vivo tumor imaging and therapeutic efficacy in animal studies. The results indicate that these peptides exhibit promising therapeutic potential by their selective binding to cancer cells including cancer stem cells.
Fields of Application:
Cancer-Targeting Peptides and Uses Thereof in Cancer Treatment and Diagnosis
Advantages when compared to the existing technologies:
- Development of structural-bioinformatics and drug-design software
- Delineation of the optimized cancer targeted peptides, as defined by binding motif Pro-X1-Leu-X2, for breast cancer and a variety of other cancers
- Development of new imaging systems for detection of tumor formation
- Development of targeting drug delivery using these novel peptides
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
